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The present investigation aims at assessing the hepatoprotective effect of saponin fraction isolated 
from the leaf of Euphorbia neriifolia on CCl4-induced hepatotoxicity on rat. CCl4 (1.5 mg/kg, i.p) is a 
potent hepatotoxic agent, which induces peroxidative degeneration of membrane lipids causing 
hypoperfusion of the membrane. Cytosolic enzymes like SGPT, SGOT and ALP elevates in the blood 
and hepatic glutathione and SOD decreases. The hepatoprotection of triterpene was compared with 
silymerin, a well known standard hepatoprotectant. Euphol was isolated from E. neriifolia leaf total 
sapogenin fraction after separation and instrumentation. Pretreatment with total saponin fraction (50, 
125 and 175 mg/kg, p.o once a day for 4 days before CCl4 and continued further for 3 days) attenuated 
the CCl4-induced acute increase in serum SGPT, SGOT and ALP activities and considerably reduced the 
histopathological alterations. Further, saponin fraction reduced thiopentone (4 mg/kg, i.p) induced 
sleeping time, suggesting the protection of liver metabolizing enzymes. Saponin administration 
replenished the depleted hepatic GSH and SOD by improving the antioxidant status of the liver. Saponin 
pretreatment improves bromsulphalein clearance and also increases the cellular viability. These effects 
substantiate protection of cellular phospholipid from peroxidative damage induced by highly reactive 
toxic intermediate radicals formed during biotransformation of CCl4.  
 





Nature has given us a large number of medicinal plants, 
some of which are yet to be explored and validated for 
their medicinal value. The 21st century has seen a para-
digm shift towards therapeutic evaluation of herbal 
products in liver diseases by carefully synergizing the 
strengths of the traditional medicine with the modern 
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Abbreviations: ENSF, Euphorbia neriifolia leaf sapogenin 
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dization and randomized placebo controlled clinical trials 
to support clinical efficacy. Several herbs are known to 
possess antioxidant properties and may be useful as liver 
protective agents. Herbs belonging to Euphorbiaceae are 
reported to have antioxidant proper-ties like triterpenes 
and flavonoids, both of which are reported to possess 
hepatoprotective and antioxidant activity (Jyothi et al., 
2008a,b) 
There are over 1500 species of Euphorbias in the world 
ranging from annual weeds to trees. Euphorbia neriifolia 
Linn. (Euphorbiaceae) grows widely around the dry, rocky 
and hilly areas of North, Central and South India. E. 
neriifolia is an herb full of spine, popularly known as 
‘sehund’ or ‘thohar’ in Hindi. Leaves are thick succulent, 6 
- 12 inch long and ovular in shape. In traditional system, 
leaves are used as aphrodisiac, diuretic, cough and cold 
treatment, bleeding piles and in ana-rectal fistula (Kirtikar 
and Basu, 1996). The tribal population of Chattisgarh 






mixture. Latex is used to de-root skin warts, earache and 
in arthritis (Anonymous, 1976). The plant is bitter, laxative, 
carminative, improves appetite, useful in abdominal 
troubles, bronchitis, tumors, leucoderma, piles, inflam-
mation, enlargement of spleen, anemia, ulcers, fever and 
in chronic respiratory troubles. Natives of Chattisgarh use 
externally boiled ‘thohar’ milk in castor oil with salt to cure 
the deep cracks in soles of legs. The milk of ‘thohar’ is 
also used commonly like aloe gel in case of burns. 
‘Thohar’ milk can be used successfully for healing of 
wounds. Application of lukewarm ‘thohar’ leaves reduces 
itching pain and swelling in piles (Oudhia, 2003).  
E. neriifolia hydroalcoholic extract was found to contain 
sugar, tannins, flavonoids, alkaloids and triterpenoidal 
saponin on preliminary phytochemical analysis. Several 
triterpenoids like glut-5-en-3β-ol, glut-5(10)-en-1-one, 
taraxerol and β-amyrin has been isolated from powdered 
plant, stem and leaves of E. neriifolia (Anjaneyulu and 
Ramachandra, 1965). Antiquorin has been isolated from 
ethanol extract of fresh root of E. neriifolia (Ng, 1990). 
Neriifolione, a triterpene and a new tetracyclic triterpene 
named nerifoliene along with euphol, was also isolated 
from the latex of E. neriifolia (Ilyas et al., 1998; 
Mallavadhani et al., 2004).  
E. neriifolia latex showed wound healing activity in 
guinea pig by increasing epithelization, angiogenesis, 
tensile strength and DNA content in wounds (Rashik et 
al., 1996). We have already reported mild central nervous 
system (CNS) depressant, wound healing and immuno-
modulatory activity of leaf hydro-alcoholic extract (Bigoniya 
and Rana, 2005, 2007, 2008a, b). Saponin separated 
from E. neriifolia leaf contains euphol as a major con-
stituent. Total saponin possesses good hemolytic and in-
vitro antioxidant activity but it is devoid of antibacterial 
activity of upto 10 mg/ml concentration (Bigoniya and 
Rana, 2006). The present study was designed to assess 
the hepatoprotective effect of separated and purified E. 
neriifolia leaf saponin fraction.  
 
 




E. neriifolia leaves were collected from cultivation field hedge plants 
of suburban areas of Bhopal (latitude 23.21°, longitude 77.84°, 
BHOP), Madhya Pradesh, India, in September 2005. The plant was 
identified with the help of available literature and authenticated by 
Dr. AP Shrivastava, taxonomist and Principal, P.K.S Government 
Ayurveda College and Institute, Bhopal, India. A voucher specimen 
was deposited in the herbarium of the department (No. 1085).  
 
 
Extraction, isolation and characterization of compound 
 
One kilogram (1 Kg) of dried powder of leaf was extracted with cold 
ethanol (70%) by maceration for seven days and solvent was 
removed under reduced pressure. Ethanolic extract gives positive 
test for reducing sugar, tannins, flavonoids, alkaloids, triterpenoidal 
saponin and absence of glycoside and fixed oil. The crude ethanolic  




extract was resuspended in water and chloroform in HCl (50% v/v) 
was added to carry out acidic hydrolysis of saponin to isolate 
sapogenins. Chloroform phase was separated and concentrated 
under 40°C up to 1/3 of the original volume. Chloroform phase was 
exhaustively extracted three times with water saturated n-butanol 
and solvent was removed under reduced pressure. Brown colour 
dried power with 2.41% of yield represents the crude sapogenin 
mixture and was designated as E. neriifolia leaf sapogenin fraction 
(ENSF). It showed positive results for Salkowski and Noller’s test.  
Total sapogenin was subjected to column chromatography on 
silica gel using chloroform, solvent gradient of chloroform/ethyl 
acetate (80:20, 60:40, 40:60 and 20:80), ethyl acetate and 
methanol. Five fractions were collected and chromatographed on 
silica gel G plates using CHCl3 : MeOH (50:50), fractions obtained 
are: Fraction-1 (mixture), Fraction-2 (ENS-1) which gives Rf value 
of 0.385, Fraction-3 (ENS-2) which gives Rf value of 0.360, 
Fraction-4 (no spot) and Fraction-5 (ENS-3) which gives Rf value of 
0.314.  
Fraction 3 gives positive teat for Salkowski and Noller’s test and 
negative result for Libermann Burchard test, indicating presence of 
triterpene. The residue obtained was carefully crystallized on 
methanol which gives a solid, white crystal (232 mg), m.p. 116°C. 
UV δ max 270 nm; IR (KBr, cm
−1
): 3400 and 1030 (3-β-OH), 2923 
and 2854, 1637 (-C=C-), 1461 and 1376, 925, 862, 802 and 723; 
1
H 
NMR (CDCl3 300 MHz): δ 5.43 (1H, t, H-24), 3.29 (1H, m, H-3β) 
1.62 (Me-26), 1.77 (Me-27), 0.74 (Me-18), 0.85 (Me-19), 0.91 (Me-
28), 1.16 (Me-29), 1.21 (Me-30), 1.12 (Me-21); 
13
C NMR (CDCl3 75 
MHz): δ 81.01 (C-3), 135.62 (C-8), 37.26 (C-20), 129.20 (C-24), 
20.18 (C-21), 17.52 (C-18), 21.14 (C-19), 18.72 (C-26), 27.32 (C-





-H2O), 297 0.24% M
+
-H2O-C8H15 and other fragments 
suggesting the fragmentation of side chain 111 (16.42% C8H15), 97 
(25.08% C7H13), 83 (42.96% C6H11), 69 (70.93% C5H9), 55 (66.15% 
C4H7) and 41 (100% C3H5). All the data were compared with 




Experimental animals  
 
Laboratory bred Wistar albino rats of both sexes (150 - 200 g) were 
maintained under standard laboratory conditions at 22 ± 2°C, 
relative humidity 50 ± 5% and photoperiod (12 h light: 12 h dark), 
were used for the experiment. Commercial pellet diet (Hindustan 
Lever, India) and water were provided ad libitum. Experimental 
protocol was approved by the Institutional Animal Ethical 
Committee (approved body of Committee for the Purpose of Control 
and Supervision of Experiments on Animals, Chenni, India) of Dr. 
H.S. Gour University, Sagar, India and care given to the animal was 
as per the WHO ‘guidelines for the care and use of animals in 
scientific research’.  
 
 
Determination of LD50  
 
Acute oral toxicity of ENSF was determined according to the 
guidelines of Organization for Economic Co-operation & 
Development (OECD) following the Up & Down method (OECD 
guideline No. 425) and Fixed dose method (OECD guideline No. 
420). Based on these methods, a limit test was performed to 
categorize the toxicity class of the compound and then main test 
was performed to estimate the exact LD50. The animals (nulliparous 
and non-pregnant female Wistar albino rats) were fasted overnight 
with free access to water, weighed and a single dose of the test 
substance was administered. Animals were observed individually 
during first 30 min, periodically during 48 h with special attention 
given during first  4 h  (short-term toxicity)  and  daily,  thereafter  for  
 




total of 14 days (short-term toxicity). LD50 was found to be greater 
than 2000 mg/kg, in limit test. The test substance could be 
classified in the hazard classification as Class 4, 300 mg/kg <LD50 
<2000 mg/kg in the globally harmonized system (GSH). LD50 of 
ENSF was found to be 979.24 mg/kg from main test (Diener et al., 




Hepatoprotective activity study 
 
In view of multiplicity and complexity of the liver functions, it is 
obvious that no single test can establish the disturbances in liver 
function. Thus, a battery of liver function test was employed for 
accurate diagnosis, to assess the severity of damage, judge 
prognosis and evaluate therapy. 
The rats were divided into six groups of six animals each. 
Animals of group I- vehicle control, group II- negative control 
(Carbon tetrachloride, 1.5 mg/kg, i.p), group III- silymerin (20 
mg/kg), group IV, V and VI were administered E. neriifolia saponin 
(ENSF) at a dose of 50, 125 and 175 mg/kg, p.o, respectively. 
Vehicle used for ENSF was propylene glycol and tween 80 in 4:1 




 were treated with 
different doses of vehicle, silymerin and ENSF for four days. On the 
4th day, 2 h after drug administration, all animals including group II 
were treated with CCl4 in liquid paraffin (1:1) in a dose of 1.5 ml/kg 
i.p. Drug treatment schedule was repeated for more three days. All 
the hepatoprotective parameters were assessed on the last day 
(7th day), 2 h after drug administration. 
 
 
Thiopentone induced sleeping time  
 
Sleeping induced by short acting barbiturate is significantly prolong-
ed in the event of any hepatic damage and this can be used as a 
measure of the function of the drug metabolizing enzymes. On the 
7th day, a single dose of thiopentone (4 mg/kg, i.p.) was given to 
the animals and the time between loss of the righting reflex and its 
recovery was taken as duration of thiopentone induced sleeping 
time (Singh et al., 2001b).  
 
 
Effect on serum biochemical parameters  
 
7th day of treatment, all the animals were sacrificed to collect liver 
and blood samples. Blood samples were centrifuged at 3000 rpm 
for 5 min, serum was collected and analyzed for estimation of 
biochemical parameters, that is, alkaline phosphatase (Kind and 
King, 1980), glutamate pyruvate transaminase and glutamate 
oxaloacetate transaminases (Reitman and Frankel, 1957), total and 
direct bilirubin (Jendrassik and Gorf, 1938), total protein (Lowry et 
al., 1951), albumin (Keyser, 1962), cholesterol (Allain et al., 1974) 
and triglyceride (McGowan et al., 1983). 
 
 
Estimation of free radical scavenging ability of liver 
 
Free radical mediated cell injury plays an important role in chemical 
induced hepatotoxicity. Liver tissues were excised, weighed, 
homogenized and supernatant was used for estimation of free 
radical scavenging ability. Glutathione reduces H2O2 directly to 







a radical transfer process, which yields thiol radicals. This thiol 
radical presents in glutathione forms a colored complex with DTNB, 
which is measured colorimetrically at 412 nm (Tietze, 1969). Lipid 
peroxidative degradation of biomembranes is one of the principal 
causes of hepatotoxicity of CCl4 (Shenoy et al., 2001). Thiobarbi-





was determined following the method of Okhawa et al. (1979). 
Superoxide dismutase was estimated as per the method of Misra 
and Fridovich (1979). 
 
 
Histopathological studies of liver  
 
The isolated liver slices were fixed in Aqua Bouin’s fluid and pro-
cessed for histopathological assessment of liver damage following 
method of Nanji et al. (2001).  
 
 
Viability study of liver cells  
 
Loss of cell viability is most often measured as loss of membrane 
integrity. This event may be primarily due to necrosis or secondarily 
due to apoptosis. Trypan blue exclusion is a cell viability assay 
based on the ability of the liver cells to exclude the trypan blue and 
uptake of the dye by the dead cells due to alteration in the mem-
brane permeability. Viability was measured by trypan blue exclusion 
test following the method of William et al. (1971). 
 
 
Bromsulphalein uptake test  
 
It is generally agreed that in the passage of bromsulphalein (BSP) 
from the plasma to the bile, it undergoes storage, metabolism and 
excretion by the liver. It is well documented that CCl4 produces 
morphological and functional changes in the liver. Bromsulphalein 
clearance test is the most sensitive and dependable method to 
assess the physiological status of liver function. The test indicates 
the excretory function of the liver. The abnormal functional effects 
produced by CCl4 are easily demonstrated by the retention of BSP. 
Liver slices kept in ice cold phosphate buffer (0.2 M) at pH 7.4 were 
incubated in media (KCl: 10 mM, MgSO4: 1 mM, NaCl: 1 mM in 
phosphate buffer) containing 30 µg BSP/ml at 38°C. An aliquot of 
reaction mixture was analyzed after 10, 20 and 30 min to determine 




Statistical analysis  
 
All data are presented as means ± SEM. Experimental data was 
analyzed using one-way ANOVA followed by student’s t-test to 
compare the difference between the control and treated values. P 
value <0.05 were considered significant. Graph Pad Prism Version 
3.02 was used for statistical calculations. 
 
   
RESULTS 
 
Thiopentone induced sleeping time 
 
E. neriifolia saponin fraction showed extremely statistical 
significant (P < 0.001) hepatoprotective (85.23%) activity 
by reducing the sleeping time to 24.25 ± 1.62 min com-
pared to 65.72 ± 2.43 min of negative control at 175 
mg/kg dose as shown in Table 1. 
 
 
Effect on serum biochemical parameters 
 
ENSF treatment significantly (P < 0.001) decreased 






Table 1. Hepatoprotective effect of E. neriifolia saponin fraction 
on thiopentone induced sleeping time against CCl4 induced 








Vehicle control 17.06 ± 1.50 --- 
CCl4 (1.5, i.p) 65.72 ± 2.43 --- 
Silymerin (20) 20.56 ± 1.08
c
 94.86 
ENSF (50) 45.78 ± 2.32
c
 40.98 
ENSF (125) 32.67 ± 2.90
c
 67.92 




Sleeping time was expressed in mean ± standard error of mean; n 
= 6. Percentage of hepatoprotection was calculated using the 
equation: H = [l − (T − V/ C − V)] × 100. Where T is mean value of 
group treated with test drug, C is mean value of group treated with 
CCl4 alone and V is the mean value of control animals. 
c 
P < 0.001 




tested doses compared to negative control group (Figure 
1). Triglyceride level was also decreased at 125 and 175 
mg/kg doses, which is extremely significant (P < 0.001). 
ENSF significantly (P < 0.001 and 0.05) increased chol-
esterol level of serum at 125 and 175 mg/kg doses. 
Saponin treatment did not have any significant effect 
towards normalization of albumin and direct bilirubin level 
in treated animals. ENSF significantly decreased serum 
total bilirubin (P < 0.001) at 175 mg/kg dose (Table 2). 
 
 
Estimation of liver free radical scavenging ability 
 
CCl4 intoxication reduced superoxide dismutase enzyme 
level expressed in unit/mg of protein in liver tissue (Table 
3). ENSF treatment showed significant (P < 0.05) enhan-
cement ability of SOD only at 175 mg/kg dose. ENSF at 
175 mg/kg dose showed extremely significant (P < 0.001) 





ENSF treatment showed hepatoprotection by reducing 
the liver weight of CCl4 intoxicated animals. Liver weight/ 
100 g of body weight for vehicle control, negative control, 
silymerin and ENSF (175 mg/kg) were 3.29, 5.18, 3.94 
and 4.02 g, respectively (Figure 2).  
Liver sections of vehicle control animals indicate 
normal appearance of hepatic parenchyma. CCl4 hepato-
toxin treated animals showed degenerative changes, bile 
duct hyperplasia, zonal necrosis plus extensive diffuse 
vacuolar degeneration engorged with blood and micro-
vesicular fatty changes in hepatocytes which indicates 
completely damaged cytoarchitecture of liver. Silymerin 
treated animals showed slightly altered hepatic parenchy-
ma   with  focal  necrosis,  lobular  necrosis, centrolobular  




necrosis and sinusiodal dilation with slightly altered heap-
tic parenchyma. ENSF (175 mg/kg) treatment showed 
sinusoidal dilation with mild focal coagulative necrosis 
and fatty vacculation of hepatic parenchyma. Histopatho-
logical observations and photomicrographs of liver slices 
are shown in Figure 3. 
 
 
Viability of liver cells 
 
ENSF treatment at all the tested doses showed extremely 
significant (P < 0.001) hepatoprotection against CCl4 by 
increasing the viable liver cell count. Silymerin showed 
87.89% of viable cell compared to 61.56% of negative 
control and 92.99% of vehicle control, respectively, as 
shown in Table 4. ENSF at 175 mg/kg dose showed 
82.93% viable liver cell.  
 
 
Bromsulphalein uptake test  
 
Liver slices of ENSF treated animals showed extremely 
statistical significant (P < 0.001) hepatoprotection (54.33%) 
at 175 mg/kg dose. It showed 75.44 ± 4.12 µg of BSP 
uptake per g of liver tissue compared to 42.11 ± 2.38 µg 





Cameron and Karunarathe first reported liver injury due 
to oral administration of carbon tetrachloride (Cameron 
and Karunarathe, 1936). CCl4 induced liver damage in 
experimental animals is a commonly used model for the 
screening of hepatoprotective drugs. The hepatotoxic 
effects of CCl4 are largely due to biotransformation by the 
cytochrome P-450 system to active metabolite, trichlo-
romethyl radical. Covalent binding of the trichloromethyl 
radical to cell protein is considered the initial step in a 
chain of events that eventually leads to lipid peroxidation 
of the cell membrane and endoplasmic reticulum. Lipid 
peroxidation in turn gives products like malondialdehyde 
(MDA) that cause damage to the membrane. The pero-
xidative products induce hypoperfusion of the membrane 
and finally cytosolic enzymes appear in the blood 
(Recknagel et al., 1989). 
Intoxicated liver prolongs duration of sleeping time for 
hexobarbitone, thiopentone, zoxazolamine and pentobar-
bitone, etc in animals due to damage of hepatic micro-
somal drug metabolizing enzymes. Thiopentone induced 
sleeping time in animals with liver intoxication is 
increased as the enzyme responsible for metabolism of 
thiopentone is reduced or destroyed (Singh et al., 2001a). 
Therefore protective effect exhibited by E. neriifolia 
saponin fraction may be due to protection of hepatic drug 
metabolizing enzymes as evidenced from decrease in 
thiopentone induced sleeping in treated animals. 
 






Figure 1. Effect of E. neriifolia saponin fraction on serum biochemical parameters of CCl4 treated 
rats. n = 6, 
b
P < 0.01, and 
c


















Vehicle control 152.60 ± 3.60 113.50± 4.55 8.88 ± 0.34 3.57 ± 0.65 0.75 ± 0.04 0.41± 0.02 
CCl4 (1.5, i.p) 68.92 ± 3.55 220.05 ± 5.72 5.85 ± 0.40 1.52 ± 0.35 8.36 ± 0.79 5.28 ± 0.68 
 Silymerin (20) 72.57 ± 3.21
ns
 131.54 ± 4.32
c
 8.46 ± 0.24
a
 2.58 ± 0.35
 ns
 0.55 ± 0.02
c
 1.15 ± 0.22
c
 




 5.92 ± 0.33
 ns
 1.39 ± 0.12
 ns
 4.25 ± 0.46
c
 5.96 ± 0.57
ns
 
ENSF (125) 89.81 ± 3.22
a
 163.99 ± 3.33
c
 6.74 ± 0.56
 ns
 2.18 ± 0.06
ns
 1.48 ± 0.25
c
 5.67 ± 0.58
ns
 
ENSF (175) 113.87 ± 3.80
c
 137.43 ± 3.80
c
 8.13 ± 0.71
a
 2.63 ± 0.21
ns
 0.98 ± 0.05
c




Values are expressed in mean ± standard error of mean; n = 6. 
a
P < 0.05, 
c
P < 0.001 and ns = not significant when compared to negative 









(unit/mg of protein) 
Lipid peroxidase 
(nmol/g of protein) 
Glutathione 
(µg/g of liver) 
Vehicle control 5.72 ± 0.87 3.43 ± 0.68 22.26 ± 1.92 
CCl4 (1.5, i.p) 1.53 ± 0.22 32.97 ± 1.75 7.46 ± 0.67 
Silymerin (20) 4.53 ± 0.62
a
 5.59 ± 0.60
c
 19.65 ± 1.40
c
 
ENSF (50) 1.95 ± 0.22
 ns
 24.25 ± 1.74
b
 10.56 ± 1.24
ns
 
ENSF (125) 3.05 ± 0.45
ns
 20.34 ± 1.09
c
 13.50 ± 1.35
a
 
ENSF (175) 4.12 ± 0.76
a
 14.70 ± 1.22
c




Values are expressed in mean ± standard error of mean; n = 6. 
a




P < 0.001 and ns = not 
significant when compared to negative control (CCl4 treated) group. 
 






Figure 2. Effect of E. neriifolia saponin fraction on relative liver weight of CCl4 treated rats. n = 6. 
c
P < 






Figure 3. Assessment of CCl4 induced hepatotoxicity by histopathology in haematoxylin-eosin stained liver 
sections. A: Section from normal liver tissue. B: Three days after CCl4 intoxication, liver tissue showing zonal 
necrosis, extensive diffuse vacuolar degeneration engorged with blood and microvesicular fatty changes in 
hepatocytes. C: Silymerin treated liver tissue showed focal necrosis, lobular necrosis and sinusiodal dilation 
with slightly altered hepatic parenchyma. D: ENSF (175 mg/kg) pretreatment showed focal coagulative 
necrosis, mild fatty vacculation and dilated sinusoids (10X). 
 




Table 4. Effect of E. neriifolia saponin fraction on viability of CCl4 treated rat liver cells.  
 
Treatment (mg/kg, p.o) Number of cell counted Number of viable cell Percent viable cell 
Vehicle control 212.33 ± 4.25 197.45 ± 2.33 92.99 
CCl4 (1.5, i.p) 205.54 ± 4.78 126.55 ± 2.79 61.56 
Silymerin (20) 207.55 ± 4.22 182.43 ± 3.43
c
 87.89 
ENSF (50) 210.17 ± 3.40 132.45 ± 3.67
c
 63.02 
ENSF (125) 207.65 ± 5.82 156.25 ± 3.32
c
 75.25 




Values are expressed in mean ± standard error of mean; n = 6. The viability was calculated as percentage from the 
following equation: % of viable cells = no. of cells excluding dye/total no. of cells counted × 100. 
c
P < 0.001 when 






Figure 4. Effect of E. neriifolia saponin fraction on BSP uptake of CCl4 treated rat liver slices. n = 6. 
c
P 




Hepatotoxin CCl4 get converted into CCl3O
− by liver 
enzymes and attacks the unsaturated fatty acids of cell 
membrane in presence of oxygen which consequently 
gives rise to lipid peroxides which alters the functional 
integrity of liver mitochondria leading to liver damage. 
The levels of marker enzymes SGOT, SGPT and ALP 
are found to be elevated in cytoplasm as well as in blood. 
Serum triglyceride and bilirubin (total and direct) level 
elevates, on the other hand serum total protein, albumin 
and cholesterol level decreases. The tendency of these 
enzymes to return to a near normal level in ENSF treated 
rats is a clear manifestation of antihepatotoxic effect of E. 
neriifolia. 
Liver toxicants cause disturbances in synthesis and 
metabolism of triglycerides, cholesterol and lipoproteins, 
thus damaging the basic resource for living cells. In CCl4 
toxicity, liver lesion develops within one-two hours, how-
ever, late toxic effects may appear after a delay of 
several hours or two to three days. The increased 
triglyceride content in the blood is in correlation with the 
fatty degeneration of the liver (Gergely et al., 1995). The 
lowering of different serum marker enzyme level is a 
definite indication of hepatoprotective action of ENSF. 
ENSF treatment caused a considerable reduction in 
serum triglyceride content and an increase in cholesterol 
level may be due to normalization of its synthesis rate.  
The lower level of total proteins recorded in the serum 
of CCl4 treated rats reveals the severity of hepatopathy. 
Hypoalbuminemia is most frequent in advanced chronic 






the severity of cellular dysfunction. ENSF normalizes 
protein content of CCl4 intoxicated rats signifying effect 
on cellular regeneration of macromolecules. Certain 
drugs like rifampin and probenecid interfere with the net 
uptake of bilirubin by the liver cell and may produce a 
mild unconjugated hyperbilirubinemia (Rubin, 1995). Both 
total and direct bilirubin level rise in disease of hepato-
cytes, obstruction to biliary excretion into duodenum, 
hemolysis, in defects of hepatic uptake and conjugation 
of bilirubin pigment such as in Gilbert’s disease. Hyper-
bilirubinemia results from impaired hepatic uptake of 
unconjugated bilirubin in liver cell injury (Recknagel et al., 
1989). ENSF treatment significantly reduced the elevated 
serum level of total bilirubin. 
Animals of negative control group significantly lost their 
body weight and showed reduced food consumption as 
compared to control group. Liver toxicity increases liver 
weight due to fatty changes along with fall in serum lipids, 
as in paracetamol intoxication. Bhanwara et al. (2000) 
reported this as a parameter in ascertaining the hepato-
protective effect of drugs. ENSF treatment showed a 
significant reversal towards loss of body weight sugges-
ting normalization of CCl4 toxicity inducing regeneration 
of hepatocytes.  
Highly reactive CCl3
-
 radical induced lipid peroxidation, 
disturbs Ca
2+
 homeostasis and finally results in cell 
death. ENSF treatment significantly increased the num-
ber of viable hepatocytes, which may be attributed to the 
inhibition of toxin induced free radical generation and in 
turn stabilizing the cell membrane. Increase in glutathione 
activity indicates the restoration of vital molecules such 
as NAD, cytochrome and glutathione. Restoration of SOD 
can help in cellular defense mechanism by preventing 
cell membrane oxidation. ENSF significantly decreased 
lipid peroxidation, by virtue of antioxidant activity. The 
saponin fraction preserved the structural integrity of the 
plasma cellular membrane of the hepatocytes and pro-
tected it from breakage by the reactive metabolites 
produced. ENSF at higher dose have significantly impro-
ved the capacity of the damaged liver to take up BSP. This 
increased uptake of BSP by the liver slices showed that it 
enhanced capacity to excrete the dye from the blood. 
Simultaneous treatment of ENSF with CCl4 exhibited 
less damage to the hepatic cells as compared to the rats 
treated with CCl4 alone. Hepatocytes showed normal 
appearance, only some cells showed higher number of 
vacuoles in the cytoplasm. Although ENSF did not 
appear to bring a complete reversal of drug-induced 
injury in the liver but had minimized the effect of CCl4. 
The histopathological observations showed a faster 
regeneration of hepatic cells which seem to suggest the 
possibility of ENSF being able to condition the hepatic 
cells to a state of accelerated regeneration, thus decrea-
sing the leakage of SGPT, SGOT and ALP into the 
circulation (Hewawasam et al., 2003). 
The hepatoprotective activity of E. neriifolia saponin 
fraction may be due to the presence of phytoactive com-
pounds which prevents liver plasma membrane alteration  




and promotes liver cell repair. The observed protective 
effect can be attributed to the presence of triterpenoidal 
saponin containing several triterpenoids like glut-5-en-3β-
ol, taraxerol, β-amyrin and euphol. Plants containing 
triterpenoidal constituents are reported to have hepato-
protective activity against ethanol, paracetamol, 
cadmium, ter-butyl hydroperoxide, galactosamine, aflato-
xin and carbon tetrachloride. Hepatoprotective effect of 
ENSF correlates to its all ready reported free radical 
scavenging and antioxidant activity (Bigoniya and Rana, 
2006). Hepatoprotective and antioxidant activity of 
Euphorbia antiquorum containing euphol (Jyothi et al., 
2008a), Euphorbia tirucalli (Jyothi et al., 2008b) and 
Euphorbia nematocypha (Ito et al., 1990) are reported. 
Alpha and beta-amyrin had been reported to have hepa-
toprotective activity against cadmium-induced hepa-
totoxicity and acetaminophen-induced liver injury, which 
is predominantly attributed to its antioxidant activity 
(Oliveira et al., 2005). In conclusion, this study supports 
the traditional use of E. neriifolia leaf as a herbal remedy 
for jaundice and other liver disorders, suggesting the 
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